Updated recommendations to minimise the risk of the rare brain infection PML with Tecfidera
Effective but Risky Treatment
Frontiers | Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
Date: 25th November 2015 Subject: Tecfidera® (dimethyl fumarate): new measures to minimise the risk of PML –enhanced monitori
Progressive multifocal leukoencephalopathy | Radiology Reference Article | Radiopaedia.org
PML in a person with multiple sclerosis | Neurology
Biogen Reports Another Tecfidera PML Case | MedPage Today
Effect of rituximab treatment in post-IRIS-PML with recurrent multiple... | Download Scientific Diagram
Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease | Nature Reviews Neurology
Frontiers | Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
Drug‐induced progressive multifocal leukoencephalopathy in multiple sclerosis: A comprehensive review - Yukitake - 2018 - Clinical and Experimental Neuroimmunology - Wiley Online Library
PML: emerging treatments and risk factor assessment
Natalizumab-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS): “a case report from Irelan
Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease | Nature Reviews Neurology
Fourth PML Case With Tecfidera in MS Calls for Vigilance
Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases - Robert Hoepner, Simon Faissner, Gisa Ellrichmann, Ruth Schneider, Ralf Gold, 2014
Natalizumab Treatment Reduced Disability With No Cases of PML in Anti-JC-Virus Antibody Negative Multiple Sclerosis - Practical Neurology
Drug‐induced progressive multifocal leukoencephalopathy in multiple sclerosis: A comprehensive review - Yukitake - 2018 - Clinical and Experimental Neuroimmunology - Wiley Online Library
Untitled
Tecfidera (dimethyl fumarate): Progressive Multifocal Leukoencephalopathy ( PML) has occurred in a patient with severe and prolon
